Biovet AD
Summary
Company ID (NIN)
112029879
Company owner / manager
- Huvepharma AD
- Other
Country
Bulgaria
Capital
6,783,000
Total assets
639,045,000
Net profit for the period
28,857,000
Report year
2018
Currency
BGN
Industry
Pharmaceuticals
Southeastern Europe Company Index (SEECI)
General information
Biovet AD is a Bulgarian veterinary medicine producer. The company manufactures antibiotic feed additives and veterinary pharmaceuticals.
The company holds the following valid certificates:
- ISO 9001:2008 Quality management systems certificate;
- OHSAS 18001:2007 Occupational health and safety management systems certificate.
Biovet AD`s products comply with the requirements of the European, British and United States Pharmacopoeia standards.
Since 2014, the company is GMP certified by the Bulgarian Institute for Control of Veterinary Medicinal Products.
Last updated on Nov 8, 2019.
Biovet JSC
Biovet PLC
History
Jan 9, 1961 - Zavod za Microbialni Preparati is established.
Nov 22, 1991 – It restructures and renames to Biovet.
Apr 16, 1996 - Biovet increases its subscribed capital to BGL 969.054 mln from BGL 51.720 mln and transforms into a joint stock company.
1998 – The company lists on the Bulgarian Stock Exchange.
Nov 27, 1998 – The Bulgarian Privatisation Agency announces its plans to sell 54% in Biovet AD to the USA-based company ICN Pharmaceuticals Inc., for USD 13.6 mln, after a tender.
Apr 7, 1999 - ICN Pharmaceuticals Inc. rejects the contract due to the NATO's bombing campaign in Kosovo.
Apr 24, 2000 – The Bulgarian Privatisation Agency sells 54% in Biovet AD to the Bulgarian Pharmaceutical Company (BPC) for USD 10.639 mln in cash.
2001 – Biovet AD establishes a retail and marketing subsidiary Biovet Europe SRL in Italy.
2002 – The company acquires a plant for the production of enzymes in Botevgrad, western Bulgaria.
June 22, 2005 – Biovet AD opens a branch in Razgrad, northeastern Bulgaria.
July 22, 2005 – The company buys veterinary drug production companies, which are owned by Iceland-based generic drug company Actavis, in Bulgaria and Macedonia. The company changes the name of its Macedonian factory to Biovet Macedonia OOD. The Bulgarian Competition Protection Commission allows Biovet AD to acquire part of Actavis' long-term assets for the production and sale of veterinary products located in Razgrad, northeastern Bulgaria.
July 18, 2005 – Biovet AD majority shareholder, Bulgarian Pharmaceutical Company, renames to Huvepharma.
July 29, 2005 – The company buys part of the feed additives business of animal healthcare firm Intervet international B.V., a part of Dutch chemical group Akzo Nobel, for EUR 22.5 mln. Biovet AD's shareholders approve the deal at an extraordinary meeting on July 15, 2005.
April 2016 - Biovet AD sets up its wholly owned subsidiary biotechnological researcher Abio EOOD.
2017 - The company establishes majority owned subsidiary BioTechIno OOD, active in biotechnological research activities, in which it holds 50.8%.
Mar 27, 2017 - Biovet AD delists from the Bulgarian Stock Exchange (Stock Symbol: 53B, ISIN: BG11BIPEAT11).
2018 - The company sets up its wholly owned energy trading company Stock Energy EOOD. Biovet AD acquires 60% in Ukrainian Evroline 2018 LLC.
Last updated on Nov 8, 2019.
Management
Contacts
4550
Peshtera, Bulgaria
+359 350 65 619
+359 350 65 637
+359 350 65 634
+359 350 65 635
+359 350 56 607
+359 350 65 636
biovet@biovet.com
salesdept@biovet.com
mts@biovet.com
Ownership
| Name | Direct holding | Indirect holding | Owner type | Country |
|---|---|---|---|---|
| Huvepharma AD | 95.54 | Company | Bulgaria | |
| Other | 4.46 | Other |
Subsidiaries and affiliates
| Name | Direct holding | Indirect holding | Country |
|---|---|---|---|
| Abio EOOD | 100.0 | Bulgaria | |
| BioTechIno OOD | 50.8 | Bulgaria | |
| Stock Energy EOOD | 100.0 | Bulgaria | |
| Evroline 2018 LLC | 60.0 | Ukraine | |
| Biovet Macedonia EOOD | 100.0 | N. Macedonia |
Products and services
Biovet AD produces and retails:
-
animal health products:
- anti-infectives;
- growth promoters;
- anticoccidials;
- active pharmaceutical substances;
- enzymes and food additives;
- crop protection products.
The company`s products are made in different forms, including powder and granulated, injectables, tablets and capsules.
Biovet AD offers more than 50 bulk substances and finished dosage forms.
Capacity
Basic profiles include:
- General information
- Contacts
- Management
- Ownership
- Employment
- Financial Information & Key Financial Ratios
Additionaly to the content in basic profiles, premium profiles include:
- Company History
- Subsidiaries & Affiliates
- Product & Services
- Capacity
- Market & Sales
- Investment Plans
Employment
Basic profiles include:
- General information
- Contacts
- Management
- Ownership
- Employment
- Financial Information & Key Financial Ratios
Additionaly to the content in basic profiles, premium profiles include:
- Company History
- Subsidiaries & Affiliates
- Product & Services
- Capacity
- Market & Sales
- Investment Plans
Market and sales
Basic profiles include:
- General information
- Contacts
- Management
- Ownership
- Employment
- Financial Information & Key Financial Ratios
Additionaly to the content in basic profiles, premium profiles include:
- Company History
- Subsidiaries & Affiliates
- Product & Services
- Capacity
- Market & Sales
- Investment Plans
Investment plans
Basic profiles include:
- General information
- Contacts
- Management
- Ownership
- Employment
- Financial Information & Key Financial Ratios
Additionaly to the content in basic profiles, premium profiles include:
- Company History
- Subsidiaries & Affiliates
- Product & Services
- Capacity
- Market & Sales
- Investment Plans
Financial information
Basic profiles include:
- General information
- Contacts
- Management
- Ownership
- Employment
- Financial Information & Key Financial Ratios
Additionaly to the content in basic profiles, premium profiles include:
- Company History
- Subsidiaries & Affiliates
- Product & Services
- Capacity
- Market & Sales
- Investment Plans